IPO Price History
Closed
Mankind Pharma Limited logo

Mankind Pharma Limited IPO

Mainboard IPOListedMANKINDNSE
Current Market Price (CMP)
₹2,212.60(+104.87%)
Current Price (CMP)
₹2,212.60(+104.87%)

Live Market Quote

Listing Price & Gain
₹1,300(+20.37%)

Day 1 Exchange Open

IPO Issue Price
₹1,080

Band: ₹1026 - ₹1080

Total Subscription
15.32x

Overall Bid Demand

Total Issue Size
—

Gross Public Offer

IPO Schedule & Key Dates

IPO Bidding Opens
25 Apr 2023
IPO Bidding Closes
27 Apr 2023
Allotment & Refunds
Completed
Exchange Listing Day
09 May 2023

IPO Subscription Status

Breakdown of institutional, high-net-worth, and retail bidding demand

Overall Demand: 15.32x
Investor CategorySubscriptionDemand Scale
Qualified Institutional Buyers (QIB)49.16x
Non-Institutional Investors (NII / HNI)3.8x
Retail Individual Investors (RII)0.92x
Total Subscription15.32x
Updated as on 27-Apr-2023 19:00:00

Listing Day & Return Performance

Listing Day Gain+20.37%
₹1,080 (Issue) → ₹1,300 (List)
Per share profit: +₹220.00
Holding Return (Till Date)+104.87%
₹1,080 (Issue) → ₹2,212.60 (CMP)
Net gain per share: +₹1132.60
Post-Listing Performance (Listing Day → Today):+70.20%

About Mankind Pharma Limited IPO

Mankind Pharma Limited is an Indian public offering categorized under the Mainboard segment. The public issue opened for bidding on 25 Apr 2023 and concluded on 27 Apr 2023, offering equity shares to institutional, non-institutional, and retail investors with an indicative price band of ₹1026 - ₹1080.

During the bidding window, Mankind Pharma Limited witnessed heavy demand with an overall subscription of 15.32 times. Institutional investors (QIB) subscribed 49.16x, non-institutional high-net-worth investors (NII) subscribed 3.8x, and retail individual investors (RII) bid 0.92x their reserved quota.

The equity shares of Mankind Pharma Limited officially debuted on the stock exchanges on 09 May 2023 at an opening listing price of ₹1,300, delivering a listing day return of +20.37% (premium) over the final issue price. As per the latest market data, the stock trades at ₹2,212.60, representing an overall gain of +104.87% since its IPO allotment.

Frequently Asked Questions

What was the issue price or price band of Mankind Pharma Limited IPO?
The issue price of Mankind Pharma Limited IPO was fixed at ₹1,080 per equity share. The indicative bidding price band was ₹1026 - ₹1080.
What were the open, close, and listing dates for Mankind Pharma Limited IPO?
Mankind Pharma Limited IPO opened on 25 Apr 2023, closed on 27 Apr 2023, listed on 09 May 2023.
How much was Mankind Pharma Limited IPO subscribed?
The IPO received an overall subscription of 15.32 times. Category-wise, QIBs subscribed 49.16x, NIIs subscribed 3.8x, and Retail investors subscribed 0.92x.
What was the listing price and listing gain of Mankind Pharma Limited IPO?
Mankind Pharma Limited IPO listed on the stock exchange at ₹1,300, delivering a listing gain of 20.37% compared to the IPO issue price of ₹1,080.
Is Mankind Pharma Limited IPO a Mainboard or SME IPO?
Mankind Pharma Limited IPO is a Mainboard IPO listed on the main exchange of NSE.
What is the current return of Mankind Pharma Limited IPO since its IPO?
At the latest market quote of ₹2,212.60, Mankind Pharma Limited IPO has generated an all-time return of +104.87% since its initial public offering.

Related Mainboard IPOs (2023)

INNOVACAP
Innova Captab Limited
₹448+0.92%
AZAD
Azad Engineering Limited
₹524+37.40%
RBZJEWEL
RBZ Jewellers Limited
₹1000.00%
MUFTI
Credo Brands Marketing Limited
₹280+0.84%